Coming out of a rough Q420 that sent the US Joint Fluid Replacement market players spinning at dizzying speed around the roulette wheel, the first quarter of 2021 gave them a bumpy ride on the road to COVID-19 recovery. As if a resurgence of positive COVID cases in late Q420 spilling into Q121 was not enough of a headwind, in mid-February, winter storms Uri and Viola landed a one-two hit across North America.
Among the many topics covered in detail in our comprehensive Q121 US Joint Fluid Replacement Market Recap* are:
The impact of the historical winter events resulted in moderate to severe disruptions to business operations. But, despite a rough start of the year, by early March, the HA market looked to be picking up and companies reported feeling more ...
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.